HER2-Positive Gastrointestinal Cancers: New Evidence and Practical Guidance With Targeted Agents
Автор: PeerView Oncology
Загружено: 2022-07-26
Просмотров: 1050
HER2-Positive Gastrointestinal Cancers: New Evidence and Practical Guidance With Targeted Agents
Co-Chairs, Elena Elez, MD, PhD, and Yelena Y. Janjigian, MD, discuss HER2+ gastrointestinal cancers in this CME/MOC activity titled “Realizing Improved Outcomes in HER2-Positive Gastrointestinal Cancers: New Evidence and Practical Guidance With Targeted Agents.” For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC information, and to apply for credit, please visit us at PeerView.com/NEB865. CME/MOC credit will be available until July 31, 2023.
Доступные форматы для скачивания:
Скачать видео mp4
-
Информация по загрузке: